))
Dr. Robert Kaufman and the new ValidCare Safety Study on CBD
Manage episode 329557448 series 2965541
Content provided by Jonathan Miller and Jonathan Miller - National Leading Hemp Attorney. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jonathan Miller and Jonathan Miller - National Leading Hemp Attorney or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Hemp Industry Episode Resources:
Host: Jonathan Miller
Guest: Dr. Robert Kaufman
Blog: Hemp Legally Speaking
Hemp Industry questions covered in the episode:
- What does the ValidCare study demonstrate about the safety of ingestible CBD?
- What did the study conclude about CBD’s liver toxicity and how does this contrast with studies done on Epidiolex, the CBD drug used by children with rare forms of epilepsy?
- How does the study address concerns about drowsiness and low testosterone?
- Statistically speaking, how strong are the study’s conclusions
- What’s the message that Dr. Kaufman will be sharing with FDA in its upcoming meeting?
61 episodes
Share
